Temsirolimus and Cetuximab in Patients With Advanced or Metastatic Solid Tumors

NCT02215720 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Patients With Advanced or Metastatic Solid Tumors

Interventions

DRUG: Cetuximab
DRUG: Temsirolimus

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris